According to Future Market Insights, the global Pharmacovigilance market is anticipated to grow with a robust CAGR of 14% from 2022 to 2032. Rapid pharmacological advancement in drug discovery in recent years has resulted in the formation of several institutional-level research and development projects, culminating in clinical trials with highly decisive outcomes. Furthermore, increased hospital admissions for various disorders are forcing healthcare facilities to streamline their procedures. As a result, the scope of pharmacovigilance…